Clinical Trial Update: A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

View source ↗

Summary

A completed retrospective observational study evaluating ustekinumab use in biologic-naive Crohn's disease patients in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Crohn Disease | Status: COMPLETED